Skip to main content
. Author manuscript; available in PMC: 2014 Aug 14.
Published in final edited form as: Cancer. 2012 May 8;118(22):5614–5622. doi: 10.1002/cncr.27593

Figure 2.

Figure 2

Forest plot depicting odds ratio for each neurotoxicity question for the 353 C-07 and Long-Term Survivors, LTS-01, patients; Odds of reporting the symptom (with severity of “somewhat,” “quite a bit,” or “very much” vs. “not at all” or a “little bit”) for FLOX divided by the odds for FULV; FULV, fluorouracil and leucovorin; FLOX, FULV plus oxaliplatin.